Predictive modeling: Employers’ new defense against kidney disease costs
Phil Albinus is a former executive editor of Employee Benefit Adviser and Employee Benefit News.
Phil Albinus is a former executive editor of Employee Benefit Adviser and Employee Benefit News.
For reprint and licensing requests for this article, click here.
As healthcare expenses approach double-digit increases, employers are looking for savings in waste, care delivery, and plan administration before cutting benefits.
Employers face another steep rise in healthcare expenses in 2027, prompting a closer look at GLP-1 coverage, pharmacy spending and high-cost conditions.
As costs to treat serious conditions surge, employers must plan how to absorb budget-altering expenses ahead of time.
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
A look at what the Medicare GLP-1 Bridge Program covers, what it doesn't, and what plan sponsors need to know.